StockWatch
·
TATA ELXSI LTD. · QQ2 FY-2027 · THE CALL

Revenue growth holds, margins expand despite wage hikes

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsTATAELXSITATA ELXSI LTD.19 Oct 2026 · 6 min read
Verdict

Buy

confidence 7/10

Credibility

Grade B

Q1 guided for high-single-digit FY27 growth, wage headwinds. Q2 delivered 15% YoY growth, offset wage impact. No numeric guidance provided; track record intact.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong Q2 delivered 15% YoY revenue growth and margin expansion (70 bps EBITDA) despite significant wage hikes, powered by operational leverage and new strategic automotive OEM deals. Key risk: Europe remains uncertain with large OEM decisions delayed; near-term upside capped until deal ramps prove material over next 2-3 quarters.

₹1055.7 Cr

Revenue · +15% YoY

₹170.3 Cr

Reported PAT · +10% YoY

Expanding

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Revenue growth 2.3% constant currency despite wage hikes

MET

Reported ₹1055.7 Cr; YoY +15%, QoQ +3.4% in INR. Constant-currency strip is realistic.

EBITDA margin expanded 70 bps QoQ to 21.9% despite wage hikes

MET

Reported OPM 21.9%, NPM 15.6%. Margin expansion over Q1 corroborated by 70 bps EBITDA claim.

Transportation vertical 2% QoQ growth; media 3.4% QoQ; healthcare 3.5% QoQ

MET

Delivered numbers support broad-based growth across segments. No contradiction evident.

Large multi-year strategic deals with automotive OEMs and aerospace suppliers won

MET

Deal wins mentioned (Sarfia Aviation, global aerospace supplier, global tech leader for GenAI). Still early-stage ramp (2-3 quarters to full scale).

Utilization 78%; headroom for leverage

MET

CFO disclosed 78% utilization vs ~81-82% pre-COVID peak. Direct quote supports claim.

Earnings quality

What changed since the last call

Deltas vs. the prior call

Wage hike impact realized; offset mastered

Neutral

Q1 flagged wage headwind; Q2 delivered 70 bps EBITDA expansion via operational leverage. Change: headwind absorbed faster than anticipated.

Strategic AI engagement announced

New

GenAI partnership with global tech leader announced. Positions for AI-first vertical; margins TBD as offering scales.

Aerospace & defense inroads concrete

Upgrade

Sarfia Aviation collaboration and global aerospace supplier deals signed. Prior: aspiration; now: 60-70% YoY growth on emerging segment.

Europe demand still uncertain

Downgrade

Q1 flagged Europe soft; Q2 confirms delay in large OEM decision-making persists. No near-term recovery visibility.

The Q&A

Analysts pressed hard on growth sustainability (Bhavik), deal ramp velocity (Sulabh, Amit), wage leverage limits (Rishi), customer concentration (Sankaranarayanan, Ankur), Europe trajectory (Rohan). Management held firm on growth momentum, disclosed utilization 78% (room to grow), clarified multi-year deals and margin bridge, acknowledged Europe uncertain but not catastrophic. No evasion detected.

The exchanges that mattered

Growth sustainability — Bhavik Mehta, JP Morgan

Answered

Growth across all verticals. Deal ramp-ups are part of model; reps time to scale (2-3 quarters). One-time FX and operational benefits reversing; operational leverage continuing.

Employee cost trajectory — Rishi Mody, Mody Advisory

Wage hikes one-time and structural; done for this year. Utilization 78% vs 81-82% pre-COVID; room to improve. Pyramid management active; expect benefit H2 H1.

Deal ramp velocity — Sulabh Govila, Morgan Stanley

Answered

Deals 2-3 quarters to full scale. Multi-year contracts protect revenue base. Supplier leakage normalizing as automotive OEM concentration drops.

AI investment ROI — Shivam, DT

Partial

AI budgets enterprise-wide transformation focus, not R&D only. Pragmatism emerging on ROI; companies demanding value linkage.

New deal margin profile — Amit Chandra, HDFC

Answered

New deals reasonably flat margin; improvement via pyramid optimization and utilization leverage over 2-3 quarters. No near-term margin accretion from new deals alone.

Guidance policy — Gaurav Ashok Bhanshali, Augmont

Answered

No formal guidance as policy. H2 expected better than H1; gradual calibrated improvement, not a jump.

New growth vectors scale — Sankaranarayanan S, ithought PMS

Partial

Aerospace/defense 60-70% YoY growth on small base. Still nascent. Diversification happening; automotive dominance persists but declining share over time.

Healthcare concentration risk — Ankur Pant, IIFL

Answered

Customer diversification improving; large deals announced (Bayer, Teruno, Japanese deals). Revenue base now broader, less US-centric. H2 > H1 expected.

Contract margins and onsite-offshore — Mayank Kumar, Prasoon Exponentials

Answered

Don't distinguish by contract type; focus on customer value add. Onsite-offshore ratio ~25:75. Room to optimize.

Europe macro and tariff risk — Rohan Nagpal, Helios Capital

Answered

Europe still uncertain; OEM decisions slow. Chinese tariffs not expected to change trajectory near-term; systemic OEM cost issues take time.

Guidance

Forward guidance and management's confidence

No formal FY27 revenue target; high-single-digit aspiration stated in Q1

Medium

Q1 guidance 'aspire for high-single-digit FY27 growth.' Q2 delivered 15% YoY, validating execution but below FY27 full-year run-rate if Q3-Q4 moderate. Management now confident on momentum.

Gradual calibrated EBITDA margin improvement H2; operational leverage to continue

Medium

Expect 2-3 quarter progressive improvement via utilization, pyramid optimization, wage hike absorption complete. Not expecting sharp inflection; margin at 21.9% is baseline.

Risks the call surfaced

Ranked by how much they should concern a holder

Europe geographic drag

Medium

Europe OEM decisions slow; automotive-heavy region faces cost pressures and electrification uncertainty. Deal closure timeline unclear.

Deal ramp-up execution risk

Medium

Large automotive OEM and aerospace deals still 2-3 quarters from full ramp. Revenue timing and margin accretion could slip if resource constraints or customer ramps delayed.

Customer concentration (Tata Motors, JLR)

Medium

Tata Motors and JLR represent material revenue; JLR acknowledged facing internal challenges (cost, EV transition). Growth in both is material but conditional on their success.

Margin leverage dependent on utilization

Low

Management's guidance for margin expansion relies on utilization improvement from 78% toward 81-82% and pyramid optimization. If deal ramps slip, utilization gains at risk.

Wage hike structural headwind

Low

Wage hikes implemented are structural (not one-time). If salary inflation continues, operational leverage gains could plateau or reverse.

Management

Score 7/10. Clear on metrics, segment-level detail. Transparent on headwinds (Europe soft, JLR challenges, wage hike absorption). Refuses to give numerical guidance (policy), which is conservative. Delivered 15% YoY revenue growth against 70 bps margin expansion despite wage hikes. Healthcare and aerospace deals executed. Q1 wage headwind predictions validated by Q2 operational leverage. Track record intact.

What to watch next
  • 1 · Q3 FY27

    Aerospace, defense, battery verticals scale-up traction

  • 2 · Q3 FY27

    Healthcare vertical rebound (management expects H2 > H1)

  • 3 · Q4 FY27

    Automotive OEM large deal ramp-up full stage (2-3Q out)

Key risk: Europe remains uncertain with large OEM decisions delayed; near-term upside capped until deal ramps prove material over next 2-3 quarters.

Informational and educational content only. Not investment advice.